0001127602-22-002347.txt : 20220128 0001127602-22-002347.hdr.sgml : 20220128 20220128113408 ACCESSION NUMBER: 0001127602-22-002347 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bihl Anthony P III CENTRAL INDEX KEY: 0001432665 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 22566348 MAIL ADDRESS: STREET 1: 807 SMITH RIDGE ROAD CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-01-26 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001432665 Bihl Anthony P III 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 Common Stock 2022-01-26 4 A 0 3012 0 A 15408 D Stock Options (Right to Buy) 20.75 2022-01-26 4 A 0 5656 0 A 2032-01-26 Common Stock 5656 5656 D These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023. These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023. /s/ F. Mark Reuter as Attorney-in-Fact for Anthony P. Bihl III 2022-01-28